Heparan Sulfate/HeparinN-Deacetylase/N-Sulfotransferase

THE N-SULFOTRANSFERASE ACTIVITY DOMAIN IS AT THE CARBOXYL HALF OF THE HOLOENZYME*

  1. Patricia Berninsone and
  2. Carlos B. Hirschberg
  1. From the Department of Molecular and Cell Biology, Boston University Goldman School of Dental Medicine, Boston, Massachusetts 02118

    Abstract

    GlycosaminoglycanN-acetylglucosaminylN-deacetylases/N-sulfotransferases are structurally related enzymes that play an important role in the biosynthesis of heparan sulfate and heparin. They are dual catalytic, single membrane-spanning polypeptides of approximately 850–880 amino acids that catalyze the N-deacetylation ofN-acetylglucosamine of glycosaminoglycans followed byN-sulfation of the same sugar. On the basis of homologies of these proteins with other N-acetylglucosaminylN-deacetylases involved in the biosynthesis of chitin and putative deacetylases from bacteria, we have constructed two soluble chimeras between protein A and the amino- and carboxyl-terminal halves of the above mastocytoma holoenzyme. The carboxyl-terminal chimera half (amino acids 479–880) was able to catalyze the N-sulfation of glucosamine of heparan sulfate with a similar affinity for its two substrates, adenosine 3′-phosphate 5′-phosphosulfate and heparan sulfate, as the holoenzyme. However, the reaction only occurred at 30 °C and not at 37 °C, both temperatures at which the holoenzyme was active. The V max of the chimera was 10–20-fold slower than that of the holoenzyme. Soluble chimeras between protein A and amino acids 43–521 and 43–680 of the holoenzyme were unable to catalyze the N-deacetylation of the bacterial N-acetylglucosaminyl-glucuronic acid polymer K5 under conditions where the holoenzyme was active. The recent appearance in genome data banks of homologs to the N-sulfotransferase domain and now the direct demonstration that this domain catalyzes this reaction raises the possibility that both N-deacetylation and N-sulfation activities of the holoenzyme might have emerged as gene fusions during evolution.

    Footnotes

    • * This work was supported by National Institutes of Health Grant GM34396.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

    • To whom correspondence should be addressed: Dept. of Molecular and Cell Biology, Boston University Goldman School of Dental Medicine, 700 Albany St., Boston, MA 02118. Tel.: 617-414-1042; Fax: 617-414-1041; E-mail: chirschb{at}bu.edu.

    • Abbreviations:
      PAPS

      adenosine 3′-phosphate 5′-phosphosulfate

      MST

      mastocytoma-derived cells

      5′-PSB

      5′ phosphosulfate binding

      3′-PB

      3′-phosphate binding.

      • Received June 26, 1998.
      • Revision received July 22, 1998.
    « Previous | Next Article »Table of Contents
    • Advertisement
    • Advertisement
    Advertisement